What does biopharma systems — other operating income mean?

This represents miscellaneous operating income or expenses that are not classified as cost of goods sold, SG&A, or R&D for the BioPharma Systems segment. It may include items such as asset impairments, restructuring charges, or gains/losses on asset sales.

Becton, Dickinson and Company BDX BioPharma Systems — Other Operating Income

Other segment segments

Medical

$17M+950%

Connected Care

-$3M-50.0%

Interventional

$0—

Medical Essentials

$0—

Similar metrics at other companies

ANABBiopharma Company — Other Nonoperating Income Expense

-$1K+85.7%

PFEBiopharma — Other Nonoperating Income (Expense)

$116M+48.7%

SNDXBiopharmaceutical Cancer Therapeutics — Other Operating Income Expense Net

$186K-15.8%

VAN

VANIBiopharm Division — Other Nonoperating Income Expense

-$209K+29.4%

ANABBiopharma Company — Nonoperating Income Expense

$2.33M-43.0%

MSIProducts and Systems Integration — Other Operating Income

-$99M-482%

Other financials

Income statement

See full

Revenue$4.7B+5.2%

Gross profit$2.2B+15.7%

Operating income$93.0M-75.7%

Net income-$311.0M-201%

EPS (diluted)-$1.11-204%

Balance sheet

See full

Cash & equivalents$1.0B+49.0%

Total debt$14.7B-16.8%

Total equity$24.1B-4.4%

Total assets$50.8B-6.7%

Cash flow

See full

Operating cash flow$671.0M—

CapEx$125.0M+9.6%

Free cash flow$546.0M—

Valuation

See full

Market cap$41.57B-16.1%

Enterprise value$55.26B-16.7%

P/E36.5×+5.3×

P/S2×-0.5×

Profitability

See full

Gross margin46.8%+2.5pp

Operating margin10.4%+0.1pp

Net margin5.3%-2.1pp

FCF margin16.4%—

Returns & leverage

See full

Return on equity4.6%-1.3pp

Debt / equity0.6×-0.1×

Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's biopharma systems — other operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Becton, Dickinson and Company's biopharma systems — other operating income?: Becton, Dickinson and Company (BDX) reported biopharma systems — other operating income of $0 in Q1 2026.
What does biopharma systems — other operating income mean?: This represents miscellaneous operating income or expenses that are not classified as cost of goods sold, SG&A, or R&D for the BioPharma Systems segment. It may include items such as asset impairments, restructuring charges, or gains/losses on asset sales.